首页> 外文期刊>Clinical and Translational Gastroenterology >Sphingosine Kinase 1 Promotes Malignant Progression in Colon Cancer and Independently Predicts Survival of Patients With Colon Cancer by Competing Risk Approach in South Asian PopulationOpen
【24h】

Sphingosine Kinase 1 Promotes Malignant Progression in Colon Cancer and Independently Predicts Survival of Patients With Colon Cancer by Competing Risk Approach in South Asian PopulationOpen

机译:鞘氨醇激酶1促进结肠癌恶性进展,并通过竞争风险方法在南亚人群中独立预测结肠癌患者的生存率Open

获取原文
       

摘要

Objectives:Sphingosine kinase 1 (SphK1) phosphorylates the membrane sphingolipid, sphingosine, to sphingosine-1-phosphate (S1P), an oncogenic mediator, which drives tumor cell growth and survival. Although SphK1 has gained increasing prominence as an oncogenic determinant in several cancers, its potential as a therapeutic target in colon cancer remains uncertain. We investigated the clinical relevance of SphK1 expression in colon cancer as well as its inhibitory effects in vitro.
机译:目的:鞘氨醇激酶1(SphK1)将膜鞘脂鞘氨醇磷酸化为鞘氨醇-1-磷酸(S1P)(一种致癌介质,可驱动肿瘤细胞的生长和存活)。尽管SphK1作为致癌决定因素在几种癌症中的地位日益提高,但其作为结肠癌治疗靶标的潜力仍不确定。我们调查了SphK1表达在结肠癌中的临床相关性及其在体外的抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号